Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Public Health and Preventive Medicine
  4. Vol 2, Issue 4, 2022

To Explore the Prevention and Treatment of Declining Ovarian Function in Contemporary Women from the Idea of "Prevention of Disease" in Traditionnal Chinese Medicine

Download as PDF

DOI: 10.23977/phpm.2022.020408 | Downloads: 9 | Views: 511

Author(s)

Rongzhu Hu 1, Xia Liu 1, Xiaoping Cui 2, Xinchun Xiao 2

Affiliation(s)

1 Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 710077, China

Corresponding Author

Rongzhu Hu

ABSTRACT

The prevalence of declining ovarian function among women in contemporary 5G life is increasing year by year, and with the gradual decline of ovarian function, more and more women are facing the threat of premature ovarian failure, which is extremely harmful, not only leading to the decline of female reproductive and endocrine function, but also leading to or aggravating multi-organ and multi-system dysfunction. The idea of "Prevention of disease" originates from the The Inner Canon of Huangdi, which is a representative academic thought of Chinese medicine, the essence of which lies in "preventing the untreated disease before it occurs, preventing changes after the disease has occurred, and preventing recurrence after the disease has occurred". Under the guidance of the idea of "treating the disease before it occurs", early identification and intervention of ovarian function decline is of great importance. 

KEYWORDS

Prevention of Disease, Declining Ovarian Function, Preventing and Treating

CITE THIS PAPER

Rongzhu Hu, Xia Liu, Xiaoping Cui, Xinchun Xiao, To Explore the Prevention and Treatment of Declining Ovarian Function in Contemporary Women from the Idea of "Prevention of Disease" in Traditionnal Chinese Medicine. MEDS Public Health and Preventive Medicine (2022) Vol. 2: 54-62. DOI: http://dx.doi.org/10.23977/phpm.2022.020408.

REFERENCES

[1] Fu H. Preventive medicine [M]. Beijing: People's Health Publishing House, 2013: 239-240. 
[2] Xu S. F., Tan Y. Exploration of the pathway of Chinese medicine evidence and treatment for low ovarian reserve function [J]. Global Chinese Medicine, 2010, 3(5): 325- -327. 
[3] Maheshwari A, Fowler P, Bhattacharya S. Assessment of ovarian reserve -should we perform tests of ovarian reserve routinely[J]. Hum Reprod, 2006, 21(11): 2729-2735. 
[4] Han Yu-Fen, Cheng Shu-Rui. Prediction and treatment of decreased ovarian reserve function [J]. Chinese Journal of Family Planning Ning, 2007, 2(136): 117. 
[5] Park JH, Rivière I, Gonen M, etal. Long-term follow- up of CD19 CAR therapy in acute lymphoblastic leuke- mia[J]. N Engl J Med, 2018, 378( 5): 449-459. doi: 10. 1056 /NEJMoa1709-919. 
[6] Hendrick V, Gitlin M, Altshuler L, etal. Antidepres- sant medications, mood and male fertility[J]. Psycho- neuroendocrinology, 2000, 25(1) : 37-51. 
[7] Le J. Obstetrics and gynecology [M]. 7th edition. Beijing: People's Health Publishing House, 2008: 309 - 321. 
[8] Sapre S, Thakur R. Lifestyle and dietary factors determine age at natural menopause[J]. J Midlife Health, 2014, 5(1):3-5. 
[9] L Gallicchio, S Miller, T Greene. Premature ovarian failure among hairdressers[J]. Human Reproduction, 2009, 24 (10): 2636-264. 
[10] Li Hao, Zhao Yingqian, Guo Yi, etal. The importance of "treating the untreated disease" in Chinese medicine [J]. Hubei Journal of Traditional Chinese Medicine, 2009, 31(9) : 31. 
[11] Li Daicui. Application of Chinese medicine theory of treating the untreated disease in the prevention and control of infectious diseases [J]. Chinese practical medicine, 2015, 10(20): 264-265. 
[12] Gallicchio L, Miller SR, Greene T, etal. Health outcomes of children born to cosmetologists compared to children of women in other occupations[J]. Reproductive Toxicology, 2010, 29(3) : 361 - 365. 
[13] Hyland A, Piazza K, Hovey KM, etal. Associations between lifetime tobacco exposure with infertility and age at natural menopause: The Womens Health Initiative Ob- servational Study[J]. Tob Control, 2016, 25( 6) : 706- 714. 
[14] Fraser A, McNally W, Sattar N, etal. Prenatal expo- sures and anti-Mullerian hormone in female adolescents: the Avon Longitudinal Study of Parents and Children [J]. Am J Epidemiol, 2013, 178( 9) : 1414-1423. 
[15] Gannon AM, Stampfli MR, Foster WG. Cigarette smoke exposure leads to follicle loss via an alternative o- varian cell death pathway in a mouse model[J]. Toxicol Sci, 2012, 125( 1) : 274-284. 
[16] Camlin NJ, Sobinoff AP, Sutherland JM, etal. Maternal smoke exposure impairs the long-term fertility of female offspring in a murine model[J]Biol Reprod, 2016, 94 ( 2) : 39. doi:10. 1095/biolreprod. 115. 135-848. 
[17] Hawkins Bressler L, Bernardi LA, De Chavez PJ, etal. Alcohol, cigarette smoking, and ovarian reserve in re- productive-age African-American women[J]. Am J Ob- stet Gynecol, 2016, 215 (6): 758. doi: 10. 1016 /j. ajog. 2016. 07. 012. 
[18] National Health Commission Contraceptive services after induced abortion have been newly standardized [J] Physician Online, 2018, 8 (0 (4)): P. 5-5 
[19] Li P, Liu Y, Wu H L etal. Effect of unwanted early pregnancy termination on ovarian function. Chinese Maternal and Child Health Care 2021 July Vol. 36, No. 14. 3298-3300. 
[20] Moyer B, Hixon ML. Reproductive effects in F1 adult females exposed in utero to moderate to high doses of mono-2-ethylhexylphthalate ( MEHP) [J]. Reprod Toxi- col, 2012, 34( 1) : 43-50. 
[21] Jin M, Yu Y, Huang H. An update on primary ovarian insufficiency [J]. Sci China Life Sci, 2012, 55(8):677-686. 
[22] Jiao X, Qin C, Li J, etal. Cytogenetic analysis of 531 Chinese women with premature ovarian failure[J]. Hum Reprod, 2012, 27( 7) : 2201-2207. 
[23] Laven JS. Genetics of early and normal menopause[J]. Semin Reprod Med, 2015, 33(6) : 377-383. 
[24] AlAsiri S, Basit S, Wood-Trageser MA, etal. Exome sequencing re- veals MCM8 mutation underlies ovarian failure and chromosomal insta-bility[J]. J Clin Invest, 2015, 125( 1) : 258-262. 
[25] Wainer-Katsir K, Zou JY, Linial M. Extended fertility and longevity: the genetic and epigenetic link [J]. Fertil Steril, 2015, 103 (5): 1117- 1124. 
[26] Von Meyenn F, Reik W. Forget the parents: epigenetic reprogramming in human germ cells [J]. Cell, 2015, 161(6): 1248-1251. 
[27] Shufelt C1, Waldman T, Wang E, etal. Female-specific factors for IHD: across the reproductive life span [J]. Curr Atheroscler Rep, 2015, 17(2):481. 
[28] Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion [J]. Fertil Steril, 2012, 98(6):1407-1415. 
[29] Liu K, Case A, Cheung AP, et al. Advanced reproductive age and fertility: no. 269, November 2011[J]. Int J Gynaecol Obstet, 2012, 117(11):95-102. 
[30] Esposito M A, Coutifaris C, Barnhart K T. A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women [J]. Hum Reprod, 2002, 17(1): 118-123. 
[31] Broekmans FJ, Kwee J, Hendriks DJ, etal. A systematic review of tests predicting ovarian reserve and IVF outcome [J]. Hum Reprod Update, 2006, 12(6):685-718. 
[32] LICCIARDI F L, LIU H C, ROSENWAKS Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulationresponse and pregnancy outcome in patients undergoing in vitro fertilization[J]. Fertil Steril, 1995, 64(5): 991-994. 
[33] LUNDING SA, AKSGLAEDE L, ANDERSON RA, etal. AMH as predictor of premature ovarian insufficiency :A longitudinal study of 120 Turner Syndrome patients[J]. J Clin Endocrinol Metab, 2015, 100(7):E1030-1038. 
[34] HEIDAR Z, BAKHTIYARI M, MIRZAMORADI M, etal. Prediction of different ovarian responses using anti-Mullerian hormone following a long agonist treatment protocol for IVF[J]. J Endocrinol Invest, 2015, 38(9):1007-1015. 
[35] YAO L, ZHANG W, LI H, etal. The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI:a meta-analysis [J]. Int J Clin Exp Med, 2015, 8(2):1755-1767. 
[36] RAEISSI A, TORKI A, MORADI A, etal. Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women [J]. Int J Fertil Steril, 2015, 9(1):27-32. 
[37] VAN ROOIJ IA, BROEKMANS FJ, SCHEFFER GJ, etal. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility:a longitudinal study [J]. Fertil Steril, 2005, 83(4):979-987. 
[38] Wu Xueqing, Kong Rui, Tian Li, etal. Expert consensus on ovarian hyporesponsiveness [J]. Reproduction and Contraception, 2015, 35(2): 71-79. 

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 1814
Visits: 84932

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.